Iohexol 300 mg I/ml versus Iopamidol 300 mg I/ml for cervical myelography double blind trial.
Valk
J
J
Crezée
F C
FC
de Slegte
R G
RG
Hazenberg
G J
GJ
Wolbers
J
J
Bach-Gansmo
T
T
D000328:Adult; D000368:Aged; D002574:Cervical Vertebrae / Q000000981:diagnostic imaging; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007472:Iohexol / Q000009:adverse effects; D007479:Iopamidol / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009192:Myelography / Q000379:methods*; D011897:Random Allocation; D013129:Spinal Puncture
D007472:Iohexol; D007479:Iopamidol